Publications by authors named "Al Benson"

100Publications

Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond.

J Natl Compr Canc Netw 2020 Sep 30:1-7. Epub 2020 Sep 30.

1Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2020.7639DOI Listing
September 2020

Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning.

J Cancer Res Clin Oncol 2020 Aug 10. Epub 2020 Aug 10.

Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Ave, Suite 1600, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-020-03354-zDOI Listing
August 2020

Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation.

Acad Radiol 2020 Jun 1. Epub 2020 Jun 1.

Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Ave, 16th Floor, Chicago, Illinois 60611; Robert Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2020.04.026DOI Listing
June 2020

Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study.

Cancer Imaging 2020 Apr 25;20(1):30. Epub 2020 Apr 25.

Department of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Ave, Suite 1600, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40644-020-00308-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183701PMC
April 2020

MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma.

J Transl Med 2020 02 10;18(1):61. Epub 2020 Feb 10.

Dept. of Radiology, Feinberg School of Medicine, Northwestern University, 737 N. Michigan Ave, Suite 1600, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-020-02246-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011246PMC
February 2020

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.

Oncologist 2020 05 19;25(5):e808-e815. Epub 2019 Nov 19.

Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216436PMC
May 2020

Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.

Oncologist 2020 01 5;25(1):33-45. Epub 2019 Aug 5.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964145PMC
January 2020

Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?

BMJ Qual Saf 2020 02 31;29(2):103-112. Epub 2019 Jul 31.

Surgical Outcomes and Quality Improvement Center, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjqs-2019-009742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382916PMC
February 2020

Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.

J Natl Compr Canc Netw 2019 07;17(7):849-854

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2018.7280DOI Listing
July 2019

Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape.

Cancer 2019 10 28;125(20):3488-3493. Epub 2019 Jun 28.

Department of Radiology, University of Michigan School of Medicine, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763351PMC
October 2019

Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients.

Curr Treat Options Oncol 2019 02 11;20(2):11. Epub 2019 Feb 11.

Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0608-7
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0608-7DOI Listing
February 2019

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies.

J Surg Oncol 2019 Jul 16;120(1):85-92. Epub 2019 Jan 16.

Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25374DOI Listing
July 2019

Pembrolizumab for the treatment of gastric cancer.

Expert Rev Anticancer Ther 2018 12 3;18(12):1177-1187. Epub 2018 Oct 3.

a Division of Hematology/Oncology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1526084DOI Listing
December 2018

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Value Health 2018 09 3;21(9):1062-1068. Epub 2018 Aug 3.

Department of Clinical Pharmacy, UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10983015183226
Publisher Site
http://dx.doi.org/10.1016/j.jval.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374027PMC
September 2018

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma.

Case Rep Oncol Med 2018 1;2018:6314392. Epub 2018 Apr 1.

Developmental Therapeutics Program, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 233 East Superior Street, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/6314392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902098PMC
April 2018

Updates on immunotherapy for colorectal cancer.

J Gastrointest Oncol 2018 Feb;9(1):160-169

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2018.01.17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848033PMC
February 2018

Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database Analysis.

Oncology 2018 6;94(5):281-288. Epub 2018 Mar 6.

Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486282DOI Listing
May 2018

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2018 04 28;36(11):1112-1120. Epub 2018 Feb 28.

Temidayo Fadelu, Sui Zhang, Robert J. Mayer, Shuji Ogino, Kimmie Ng, Jeffrey Meyerhardt, and Charles S. Fuchs, Dana-Farber/Partners CancerCare; Shuji Ogino, Kana Wu, Walter Willett, and Edward Giovannucci, Harvard TH Chan School of Public Health; Shuji Ogino, Edward Giovannucci, and Ying Bao, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham; Michael Messino, Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al B. Benson, Robert H Lurie Comprehensive Cancer Center, Northwestern University; Hedy L. Kindler, University of Chicago Comprehensive Cancer, Chicago, IL; Daniel M. Atienza, Virginia Oncology Associates, Norfolk, VA; Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA; and Charles S. Fuchs, Yale Cancer Center, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891130PMC
April 2018

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors.

Am Health Drug Benefits 2017 Nov;10(8):408-415

Professor of Medicine, and Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726060PMC
November 2017

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis.

World J Gastroenterol 2017 09;23(33):6128-6136

Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v23.i33.6128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597504PMC
September 2017

Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.

J Vasc Interv Radiol 2017 Nov 30;28(11):1520-1526. Epub 2017 Jun 30.

Department of Radiology, Northwestern University Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611-2927. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2017.05.011DOI Listing
November 2017

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR.

J Med Econ 2017 Sep 19;20(9):945-951. Epub 2017 Jun 19.

c Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2017.1337019DOI Listing
September 2017

Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer.

Am Soc Clin Oncol Educ Book 2017 ;37:232-245

From the Dana-Farber Cancer Institute, Boston, MA; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Sage Bionetworks, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175660DOI Listing
December 2017

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

J Clin Oncol 2017 Feb 14;35(4):446-464. Epub 2016 Nov 14.

Angela N. Bartley, St Joseph Mercy Hospital, Ann Arbor, MI; Mary Kay Washington, Vanderbilt University Medical Center, Nashville, TN; Carol Colasacco and Christina B. Ventura, College of American Pathologists, Northfield; Al B. Benson III, Northwestern University, Chicago, IL; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Alfredo Carrato, Ramón y Cajal University Hospital, Madrid, Spain; Margaret L. Gulley, University of North Carolina, Chapel Hill, NC; Dhanpat Jain, Yale University School of Medicine, New Haven, CT; Sanjay Kakar, University of California, San Francisco, CA; Helen J. Mackay, Princess Margaret Cancer Centre; Catherine Streutker, St Michael's Hospital, University of Toronto, Toronto, Canada; Laura Tang, Memorial Sloan Kettering Cancer Center, New York, NY; Megan Troxell, Stanford University Medical Center, Stanford, CA; and Jaffer A. Ajani, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4836DOI Listing
February 2017

Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.

N Engl J Med 2017 01;376(2):125-135

From the Moffitt Cancer Center, Tampa, FL (J.S., G.E.-H.); Markey Cancer Center, University of Kentucky, Lexington (E.W.); Cedars Sinai Medical Center, Los Angeles (A.H.), and Stanford University School of Medicine, Stanford (E.M., P.L.K.) - both in California; University of Texas M.D. Anderson Cancer Center (J.Y., B.C.) and Excel Diagnostics Imaging Clinic (E.D.), Houston; Dana-Farber Cancer Institute, Boston (M.H.K., H.J.); University of Iowa, Iowa City (D.B., T.M.O.); Zentralklinik, Bad Berka (R.P.B., H.R.K.), and Charité-Universitätsmedizin, Berlin (M.P.) - both in Germany; Royal Free Hospital (M.C.) and King's College Hospital NHS Foundation Trust (R.S.), London, and Beatson Oncology Centre, Glasgow (N.R.) - all in the United Kingdom; Hôpital Beaujon, Clichy (R.L., P.R.), and Advanced Accelerator Applications, St. Genis-Pouilly (T.T.) - both in France; Mayo Clinic College of Medicine, Rochester, MN (T.H.); University Hospitals and KU Leuven, Leuven, Belgium (E.V.C.); Robert H. Lurie Comprehensive Cancer Center, Chicago (A.B.); Hospital Universitari de Bellvitge, Barcelona (J.M.), and Hospital Universitario Ramón y Cajal, Madrid (E.G.) - both in Spain; Vanderbilt University Medical Center, Nashville (J.B.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan (E.S.); University Hospital, Uppsala University, Uppsala, Sweden (K.O.); Advanced Accelerator Applications USA, New York (M.L.S., P.S., J.L.E.); and Erasmus Medical Center, Rotterdam, the Netherlands (D.K., E.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895095PMC
January 2017

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

J Clin Oncol 2017 Mar 9;35(7):718-726. Epub 2017 Jan 9.

Madhur K. Garg, Joseph A. Sparano, and Shalom Kalnicki, Montefiore Medical Center, Albert Einstein College of Medicine, Montefiore-Einstein Center for Cancer Care, Bronx, NY; Fengmin Zhao, Dana Farber Cancer Institute, Boston, MA; Joel Palefsky, University of California, San Francisco, CA; Richard Whittington, Philadelphia VA Medical Center; Edith P. Mitchell, Thomas Jefferson University, Philadelphia, PA; Mary F. Mulcahy and Al B. Benson III, Northwestern University, Chicago, IL; Karin I. Armstrong, United Hospital, Woodbury, MN; Nassim H. Nabbout, Cancer Center of Kansas, Wichita, KS; Bassel F. El-Rayes, Emory University, Atlanta, GA; Adedayo A. Onitilo, Marshfield Clinic, Marshfield, WI; Daniel J. Moriarty, Overlook Medical Center, Summit, NJ; and Thomas J. Fitzgerald, Imaging and Radiation Oncology Core, Quality Assurance Review Center, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.1667
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.1667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455423PMC
March 2017

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.

J Natl Compr Canc Netw 2016 12;14(12):1528-1534

From Division of Surgical Oncology, The Ohio State University Wexner Medical Center/Arthur G. James Cancer Hospital, Columbus, Ohio; Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; University of Texas MD Anderson Cancer Center, Houston, Texas; Kalispell Regional Healthcare Specialists, Kalispell Regional Healthcare, Kalispell, Montana; Memorial Sloan Kettering Cancer Center, New York, New York; Dana-Farber Cancer Institute, Boston, Massachusetts; and Depaartment of Medicine, Division of Hematology/Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292039PMC
http://dx.doi.org/10.6004/jnccn.2016.0164DOI Listing
December 2016

Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?

Authors:
Al B Benson

Clin Adv Hematol Oncol 2016 Oct;14(10):778-781

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
October 2016

Epidemiology of Anal Canal Cancer.

Surg Oncol Clin N Am 2017 01;26(1):9-15

Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 676 N Saint Clair, Suite 850, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.07.001DOI Listing
January 2017

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Arch Pathol Lab Med 2016 Dec 14;140(12):1345-1363. Epub 2016 Nov 14.

From the Department of Pathology, St. Joseph Mercy Hospital, Ann Arbor, Michigan (Dr Bartley); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Washington); Surveys (Ms Ventura) and Governance (Ms Colasacco), College of American Pathologists, Northfield, Illinois; Quality and Guidelines Department, American Society of Clinical Oncology, Alexandria, Virginia (Dr Ismaila); the Division of Hematology/Oncology, Northwestern University, Chicago, Illinois (Dr Benson); Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain (Dr Carrato); the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (Dr Gulley); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Jain); the Department of Pathology and Laboratory Medicine, UCSF, San Francisco, California (Dr Kakar); the Division of Medical Oncology and Hematology, University of Toronto/Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada (Dr Mackay); the Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada (Dr Streutker); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Tang); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Troxell); and the Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston (Dr Ajani).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0331-CPDOI Listing
December 2016

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Gastroenterology 2016 12 27;151(6):1155-1163.e2. Epub 2016 Aug 27.

Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.08.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124387PMC
December 2016

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.

Pancreas 2016 11;45(10):1485-1493

From the *Yale Center for Pancreatic Disease, Yale School of Medicine, New Haven, CT; †Statistics and Data Management Center, NRG Oncology, Philadelphia, PA; ‡Department of Medicine, John A Burns School of Medicine, University of Hawaii, Honolulu, HI; §Department of Radiation Oncology, University of Maryland, Baltimore, MD; ∥Oncology Program, Toledo Clinic, Toledo, OH; ¶Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; #Saint Vincent Comprehensive Cancer Center, New York; and **The Oncology Consortia of Criterium Inc, Saratoga Springs, NY; ††California Cancer Institute, Temple City, CA; ‡‡Graduate Institute of Medical Sciences, College of Medicine, and §§Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; ∥∥Department of Pathology, Cross Cancer Center, University of Alberta, Edmonton, Alberta, Canada; ¶¶Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL; ##Karmanos Cancer Institute; and ***Department of Oncology and Cancer Biology Graduate Program, Wayne State University, Detroit, MI; †††Department of Radiation Oncology, Montifiore Medical Center, Bronx, NY; and ‡‡‡Department of Radiation Oncology, The Canberra Hospital, Australian National University, Canberra, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119656PMC
November 2016

Is There Efficacy Beyond Cytotoxic Chemotherapy for Pancreatic Cancer?

J Oncol Pract 2016 09;12(9):806-7

Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.015883DOI Listing
September 2016

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

J Oncol Pract 2016 11 31;12(11):1101-1113. Epub 2016 Oct 31.

Center for Business Models in Healthcare; Northwestern University, Chicago, IL; University of Michigan Health System; University of Michigan Medical School, Ann Arbor, MI; ECOG/ACRIN Cancer Research Group, Philadelphia, PA; National Breast Cancer Coalition, Washington, DC; Genentech, South San Francisco, CA; Albert Einstein Cancer Center; Albert Einstein College of Medicine, Bronx; The Leukemia & Lymphoma Society, Rye Brook, NY; Brown University School of Public Health, Providence, RI; Wake Forest University School of Medicine; and Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455414PMC
November 2016

Neoadjuvant treatment of rectal cancer: where are we now?

Gastroenterol Rep (Oxf) 2016 Aug 12;4(3):206-9. Epub 2016 Jul 12.

Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/gastro/gow017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976683PMC
August 2016

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.

J Clin Oncol 2016 08 5;34(23):2736-42. Epub 2016 Jul 5.

Peter C. Enzinger and Robert J. Mayer, Dana-Farber Cancer Institute, Harvard Medical School, and Alliance for Clinical Trials in Oncology, Boston, MA; Barbara Ann Burtness and Steven J. Cohen, Fox Chase Cancer Center; Barbara Ann Burtness, Steven J. Cohen, and Al Bowen Benson III, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Philadelphia, PA; Donna Niedzwiecki, Xing Ye, and Kathe Douglas, Alliance Statistics and Data Center, Duke University, Durham, NC; David H. Ilson, Memorial Sloan Kettering Cancer Center and Alliance for Clinical Trials in Oncology, New York, NY; Victoria Meucci Villaflor, University of Chicago Medicine and Alliance for Clinical Trials in Oncology; Al Bowen Benson III, Northwestern University Feinberg School of Medicine, Chicago, IL; Alan Venook, University of California San Francisco Helen Diller Family Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, San Francisco, CA; and Richard M. Goldberg, Ohio State University James Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, Columbus, OH.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/06/30/JCO.2015.65
Web Search
http://dx.doi.org/10.1200/JCO.2015.65.5092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019745PMC
August 2016

Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.

Cancer J 2016 May-Jun;22(3):182-9

From the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000192DOI Listing
January 2017

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2016 08 31;34(22):2654-68. Epub 2016 May 31.

Edward P. Balaban, Cancer Care Partnership, State College; Edward P. Balaban and Nelson S. Yee, Penn State Hershey Cancer Institute, Hershey, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Alok A. Khorana, Cleveland Clinic; Jennifer R. Eads, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH; Manish A. Shah, The Weill Cornell Medical Center; Peter Allen, Memorial Sloan Kettering Cancer Center, New York, NY; Somnath Mukherjee, University of Oxford, Oxford, United Kingdom; Christopher H. Crane and Milind M. Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Andrew H. Ko, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Anitra Engebretson, Patient Representative, Portland, OR; Joseph M. Herman, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; John H. Strickler, Duke University Medical Center, Durham, NC; Al B. Benson III, Lurie Comprehensive Cancer Center of Northwestern, Chicago, IL; and Susan Urba, University of Michigan Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5561DOI Listing
August 2016

Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.

J Clin Oncol 2016 Feb 23;34(5):469-78. Epub 2015 Dec 23.

Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center; Neal J. Meropol, Tyler G. Kinzy, Tasnuva M. Liu, Seunghee Margevicius, Dawn M. Miller, and Mark D. Schluchter, Case Comprehensive Cancer Center, Case Western Reserve University; Anne Lederman Flamm, Cleveland Clinic Foundation, Cleveland, OH; Yu-Ning Wong, Suzanne M. Miller, Michael Collins, Brian Egleston, and Eric Ross, Fox Chase Cancer Center, Temple University Health System; Joanne Buzaglo, Cancer Support Community Research and Training Institute; Linda Fleisher, Children's Hospital of Philadelphia; David Poole, University of Pennsylvania Health System, Philadelphia, PA; Terrance Albrecht, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Sharon Manne, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Al Bowen Benson III, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; Michael Katz, International Myeloma Foundation, North Hollywood, CA; and Nancy Roach, Fight Colorectal Cancer, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.2257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872012PMC
February 2016

Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

J Clin Oncol 2016 Feb 23;34(5):479-87. Epub 2015 Dec 23.

Yu-Ning Wong, Michael Collins, Suzanne M. Miller, Stephanie Raivitch, and Eric Ross, Fox Chase Cancer Center, Temple University Health System; Joanne Buzaglo, Cancer Support Community Research and Training Institute; Linda Fleisher, Children's Hospital of Philadelphia; David Poole, University of Pennsylvania, Philadelphia, PA; Mark D. Schluchter, Tyler G. Kinzy, Tasnuva M. Liu, Seunghee Margevicius, Dawn M. Miller and Neal J. Meropol, Case Comprehensive Cancer Center, Case Western Reserve University; Neal J. Meropol, University Hospitals Case Medical Center, Seidman Cancer Center; Anne Lederman Flamm, Cleveland Clinic Foundation, Cleveland, OH; Terrance L. Albrecht, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Al Bowen Benson III, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; Michael Katz,† International Myeloma Foundation, North Hollywood, CA; Sharon Manne, Cancer Institute of New Jersey, New Brunswick, NJ; and Nancy Roach, Fight Colorectal Cancer, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.2463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872013PMC
February 2016

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.

J Nucl Med 2016 May 3;57(5):665-71. Epub 2015 Dec 3.

Section of Interventional Radiology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital, Chicago, Illinois Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.166082DOI Listing
May 2016

Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.

Ann Surg 2016 Feb;263(2):392-8

*Northwestern Institute for Comparative Effectiveness Research (NICER) in Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL †Surgical Oncology and Quality Improvement Center, Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL ‡Department of Surgery, Massachusetts General Hospital, Boston, MA §Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL ¶Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL ||Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL **Cancer Programs, American College of Surgeons, Chicago, IL ††Department of Surgery, NorthShore University HealthSystem, Evanston, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001052DOI Listing
February 2016

Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.

Clin Colorectal Cancer 2016 Mar 26;15(1):37-46. Epub 2015 Jul 26.

Center for Pain Studies, Rehabilitation Institute of Chicago and Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.07.001DOI Listing
March 2016